Article
Management of Neurofibromatosis Type 2-Associated Vestibular Schwannomas.
Otolaryngologic clinics of North America - 1 Jun 2023
Jiramongkolchai Pawina, Schwartz Marc S, Friedman Rick A
Abstract excerpt
Neurofibromatosis type 2 (NF2) is an autosomal dominant syndrome caused by a mutation in the NF2 suppressor gene and is characterized by the development of multiple benign tumors throughout the central nervous system. Bilateral vestibular schwannomas (VSs) are pathognomonic for NF2 and are associated with progressive hearing loss and eventual deafness in most patients. This review presents current management...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
